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Abstract
Introduction The aim of the study was to compare the effectiveness of cognitive behavioural therapy interventions for 
insomnia (CBT-I) to that of a sleep hygiene intervention in a randomized controlled design among shift workers. We also 
studied whether the features of shift work disorder (SWD) affected the results.
Methods A total of 83 shift workers with insomnia disorder were partially randomized into a group-based CBT-I, self-help 
CBT-I, or sleep hygiene control intervention. The outcomes were assessed before and after the interventions and at 6-month 
follow-up using questionnaires, a sleep diary, and actigraphy.
Results Perceived severity of insomnia, sleep-related dysfunctional beliefs, burnout symptoms, restedness, recovery after a 
shift, and actigraphy-based total sleep time improved after the interventions, but we found no significant differences between 
the interventions. Mood symptoms improved only among the group-based CBT-I intervention participants. Non-SWD par-
ticipants had more mental diseases and symptoms, used more sleep-promoting medication, and had pronounced insomnia 
severity and more dysfunctional beliefs than those with SWD. After the interventions, non-SWD participants showed more 
prominent improvements than those with SWD.
Conclusions Our results showed no significant differences between the sleep improvements of the shift workers in the 
CBT-I interventions and of those in the sleep hygiene control intervention. Alleviation of mood symptoms seemed to be 
the main added value of the group-based CBT-I intervention compared to the control intervention. The clinical condition 
of the non-SWD participants was more severe and these participants benefitted more from the interventions than the SWD 
participants did.
Trial registration ClinicalTrials.gov, NCT02523079.
Keywords Insomnia · Cognitive behavioural therapy for insomnia · Self-help · Sleep hygiene education · Shift work · Shift 
work disorder · Occupational health services
Introduction
Insomnia affects a large proportion of the population 
(Morin et al. 2015). Approximately 30% of the popula-
tion have recurring insomnia symptoms and 5–10% have 
chronic insomnia disorder that includes wake-time symp-
toms (Partinen and Hublin 2011). In Finland, the preva-
lence of insomnia-related symptoms among the working-
age population has increased from 20 to 30% in the 1970s 
to as high as 40–45% in the 2000s (Kronholm et al. 2016). 
Identifying and treating insomnia efficiently is important 
because of its high prevalence and because it increases 
the risks of both mental and somatic diseases (Baglioni 
et al. 2012; Sivertsen et al. 2014; Vgontzas et al. 2013) and 
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reduces work and cognitive ability (Fortier-Brochu et al. 
2012; Kucharczyk et al. 2012).
Insomnia is even more common among shift workers 
(Kerkhof 2018). This is probably related to the temporal 
misalignment of the homeostatic and circadian processes 
of sleep associated with irregular shifts (West and Bech-
told 2015). Today, approximately one-fifth of the Euro-
pean Union (EU) employees work in shifts (Eurofound 
2017), making shift workers a significant group of people 
whose potential insomnia should be managed using effec-
tive interventions.
Cognitive behavioural therapy for insomnia (CBT-I) is 
effective in a variety of patient populations and settings 
(Morin et al. 2015). Patient-reported outcomes, such as the 
Insomnia Severity Index (ISI) (Morin et al. 2011), estimate 
that 70–80% of patients achieve a response, and improve-
ments in sleep continuity and efficiency have medium to 
large effect sizes on average (Morin et al. 2015). Based 
on the European guidelines for the treatment of insom-
nia, CBT-I is recommended as the first-line treatment for 
chronic insomnia (Riemann et al. 2017). However, only 
a few CBT-I effectiveness studies have been conducted 
among shift workers. Earlier non-randomized studies 
have shown that CBT-I may also be effective among shift 
workers (Jarnefelt et al. 2012; Peter et al. 2019). On the 
other hand, one study found that CBT-I implemented at the 
workplace was only effective when shift workers were not 
included in the analyses (Schiller et al. 2018).
Shift workers’ irregular sleep–wake patterns are a chal-
lenge in the screening and treatment of insomnia. Firstly, it 
may be difficult to distinguish between insomnia disorder 
and shift work disorder (SWD) (American Academy of 
Sleep Medicine 2014). SWD is a clinical circadian rhythm 
sleep disorder defined as insomnia and/or excessive sleepi-
ness that lasts at least 3 months and is associated with a 
prolonged shift work schedule that overlaps habitual sleep-
ing time. Its etiology is primarily attributed to circadian 
disruption and misalignment due to shift work, and its 
prevalence rate is estimated to be 10–23% among rotat-
ing shift and night workers (Wright et al. 2013). A num-
ber of treatment efforts have targeted the core features of 
shift work and focused on improving circadian adaption 
and sleep and reducing sleepiness (Wickwire et al. 2017). 
From an organizational perspective, SWD must be handled 
within the broader context of fatigue risk management and 
prevention. In practice, SWD and insomnia disorder may 
coexist, which may complicate screening of and treat-
ment decisions regarding insomnia among shift workers 
(Drake et al. 2004). For example, insomnia may initially be 
associated with the shift work schedule but may progress 
into insomnia even on days off (Wright et al. 2013). Sec-
ondly, following a regular sleep/wake pattern is one central 
principle of CBT-I (Morin et al. 2015) that shift workers 
cannot do. This is why a modified version of CBT-I has 
been applied (Jarnefelt et al. 2012).
Because shift workers with irregular schedules may find 
it difficult to participate in regularly scheduled face-to-
face treatment typically used in the group treatment con-
text, self-help treatments, such as mobile applications, are 
needed (Wickwire et al. 2017). Although self-help CBT-I 
treatments are shown to be effective (Cheng and Dizon, 
2012), they need further validation (Morin et al. 2015). This 
is particularly the case for shift workers because relatively 
few controlled intervention studies have been conducted on 
health and sleep problems and the self-help perspective, in 
particular, has not yet been systemically studied among this 
group (Kecklund and Axelsson 2016).
Good sleep hygiene practices are considered a critical 
step in any sleep treatment approach among shift workers 
(Wickwire et al. 2017). Sleep hygiene education refers to 
behavioural, environmental, and other sleep-related recom-
mendations to help patients improve their sleep (Stepanski 
and Wyatt 2003). However, though epidemiological and 
experimental research generally supports an association 
between individual sleep hygiene recommendations and 
nocturnal sleep, the direct effects of these recommendations 
on sleep remain largely untested in the general population 
(Irish et al. 2015). Compared to CBT-I, there is also little 
evidence that sleep hygiene education alone is effective in 
the treatment of insomnia disorder (Morin et al. 2015). The 
role of sleep hygiene education should be compared to that 
of CBT-I in the treatment of insomnia among shift workers.
As occupational health services (OHS) cover 84% of the 
employed workforce in Finland (Lappalainen et al. 2016), it 
is essential that OHS personnel are able to provide effective 
insomnia treatments. The aim of our study was to evalu-
ate the effectiveness of group-based CBT-I (gCBT-I) and 
self-help-based CBT-I (sCBT-I) interventions compared to 
a sleep hygiene (SH) control intervention in a randomized 
and controlled design among shift workers with insomnia 
in an OHS setting. We studied the differences between and 
the effectiveness of treatment methods on self-appraised 
severity of insomnia, sleep-related dysfunctional beliefs, 
subjective and objective insomnia symptoms, sleep, and 
alertness. Based on the bidirectional relationship between 
insomnia and medical and psychiatric morbidity and quality 
of life, recommendations for a standard research assessment 
of insomnia include measuring waking correlates and the 
consequences of insomnia (Buysse et al. 2006; Morin et al. 
2015). In this study, we assessed the differences between 
the improvements caused by the different interventions to 
the waking correlates, including burnout symptoms, depres-
sion symptoms, trait of worry, and health-related quality of 
life. Finally, we evaluated whether SWD features were asso-
ciated with the results. We hypothesized that participants 
with SWD features benefit less than participants without 
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these features because the insomnia symptoms of SWD are 
primarily associated with circadian disruption and misalign-




We recruited volunteer shift workers from the personnel 
of Helsinki city hospitals, the City of Turku, an airline, a 
bakery, and a media company. Recruitment was organized 
by OHS and via the intranet or leaflets at the workplaces. 
In addition, the Finnish Institute of Occupational Health 
(FIOH) recruited shift workers through advertisements 
posted in the commercial press, on their website, and on 
their Facebook and Twitter accounts. Recruitment began in 
May 2015 or August 2016, depending on the partner, and 
ended in May 2017. However, the individual assessment and 
treatment process began immediately after each participant 
was recruited.
In OHS, the recruitment and assessment process pro-
ceeded as follows: (1) A nurse met the interested subject, 
provided information on the study, and assessed inclusion/
exclusion criteria based on the candidate’s age, insomnia 
duration, working hours, and work situation; (2) suitable 
candidates kept a sleep diary for 2 weeks and replied to a 
modified semi-structured sleep and health questionnaire 
(Partinen and Gislason 1995) and a questionnaire with 
shift-specific questions on insomnia and sleepiness (SS-Q) 
(Vanttola et al. 2018) and the Insomnia Severity Index (ISI) 
(Morin et al. 2011); (3) the candidate attended an appoint-
ment with a physician who decided on inclusion/exclusion 
based on the clinical interview and examination, sleep diary, 
and questionnaire results. All the selected participants gave 
their informed consent. The FIOH assessment process had 
one exception: a sleep medicine specialist (CH) and clinical 
psychologist and psychotherapist specialized in insomnia 
and CBT-I (HJ) made preinclusion or exclusion decisions 
based on short electronic questionnaires on age, working 
hours, insomnia symptoms, illnesses, and medications. This 
exception was made because, unlike in the recruiting OHS 
centers, the participants’ previous health histories were not 
available at the FIOH. After this preinclusion, the suitable 
candidates met a nurse.
The FIOH sleep medicine specialist and psychologist 
gave all the OH nurses and physicians a two-hour course on 
the study plan, the clinical assessment of insomniacs, and 
inclusion and exclusion criteria. The physicians and nurses 
were able to consult the FIOH specialists when needed 
during the assessments. We used the following inclusion 
criteria: (1) age of 20‒60 years; (2) non-organic insomnia 
(F51.0) (World Health Organization 1995); (3) difficulty 
initiating [sleep onset latency (SOL)] and/or maintaining 
sleep [wake after sleep onset (WASO)] for ≥ 30 min and/
or use of sleep-promoting medication (SPM) at least three 
nights per week for at least 3 months (Buysse et al. 2006); 
(4) motivation to receive non-pharmacological treatment for 
insomnia; (5) full-time (80–100%) shift work, which was 
defined as working hours consisting of at least 10% of morn-
ing shifts (beginning 07:00 or earlier), evening shifts (end-
ing 22:00 or later) or night shifts (at least 3 hours of a shift 
falling between 23:00 and 06:00). This cut-off score of 10% 
was considered a minimum exposure level to shift work. In 
addition, participants had to work at least two shift types 
(e.g. morning and night shifts) and (6) be fluent in Finnish, 
as the intervention materials were in Finnish. We considered 
non-assessed or untreated clinically significant somatic or 
mental symptoms or illnesses or other sleep disorders that 
could explain current insomnia symptoms or interfere with 
or be worsened by CBT-I as exclusion criteria for the study.
Figure 1 represents the participant flowchart. A total of 
112 candidates were assessed for eligibility. Other untreated 
sleep problems, e.g. restless legs syndrome, were the main 
reason for exclusion (19 women and 10 men; mean (M) age 
42.5, standard deviation (SD) 10.4 years). This resulted in a 
total of 83 participants, who were randomized into the inter-
ventions. Eight participants discontinued before the study 
measurements (6 women, 2 men; M age 42.3, SD 6.2 years).
The demographic and clinical characteristics of the sam-
ple attending the before intervention (T1) measurements 
are presented in Table 1. The participants were middle-
aged [median (Mdn) 45, range (RG) 21 − 60 years] and 75% 
were women. A total of 45% worked in the health and social 
care e.g. as nurses, 17% worked in a bakery and 12% in 
the aviation industry e.g. as cabin attendants. One-quarter 
worked in e.g. the security and land transportation fields. 
Over half (53%) had a three-shift work schedule, nearly a 
quarter (24%) worked irregular hours, and the rest had a two-
shift work schedule. On average, 16.5 (SD 6.1) of all shifts 
per month were either early morning (35%; M 5.8, SD 4.9), 
evening (41%; M 6.7, SD 3.6), or night (24%; M 4.0, SD 3.2) 
shifts. The total duration of shift work averaged 16 years.
Participants had suffered from insomnia from 9 months 
to 25 years. The ISI sum score (Bastien et al. 2001) in the 
assessment phase showed moderately severe clinical insom-
nia on average. Sixty-four per cent had used SPM during the 
last 3 months (31% at least three times a week, 11% once 
or twice a week, and 23% less often). SWD features were 
evaluated based on the SS-Q and the sleep diary from the 
assessment phase. A participant was evaluated as having 
SWD if they had suffered from insomnia symptoms and/or 
sleepiness during the last 3 months always or often during 
the early morning, evening, and/or during the night shifts, 
and never or rarely on holidays and days off (Vanttola et al. 
538 International Archives of Occupational and Environmental Health (2020) 93:535–550
1 3
2018). In accordance to the clinical criteria of SWD (Ameri-
can Academy of Sleep Medicine 2014), based on their sleep 
diaries the participants also had to have averaged at least one 
hour less sleep on the early morning, evening, and/or night 
shift days than on day shift days or days off. Based on these 
criteria, the number of SWD and non-SWD participants 
equaled one and other (one participant was excluded from 
the analysis because her SWD features could not be evalu-
ated, as she had not worked shifts during the assessment 
phase). Approximately half of the participants (51%) had 
some diagnosed comorbid physical disease, most commonly 
hypertension (10 participants), allergy (9), hypothyroidism 
(9), migraine (7), and pain symptoms (7); and 8% had a diag-
nosed mental disease, most commonly depression (6). How-
ever, all physical and mental diseases were under balanced 
treatment. β-blockers (10 participants), antihistamines (9), 
and thyroxine (9) were the concurrent pharmacological treat-
ments for comorbid diseases. The described demographic 
and clinical characteristics of the participants randomized 
into the interventions did not differ significantly when we 
accounted for those who discontinued before T2 measure-
ments or when we excluded them.
The participants recruited by OHS (50 participants) 
differed from those recruited by FIOH (25 participants) 
in two demographic characteristics. The participants 
recruited by OHS had longer experience with shift work 
than those recruited by FIOH  [t73 = 3.00, p = 0.004; on 
average 18.4 (SD 8.6) vs. 12.2 (SD 8.1) years]. They also 
differed in terms of their professional fields ( 2
3
 = 19.04, 
p < 0.001). The proportions of bakery (OHS 26% vs. 
FIOH 0%) and aviation (16% vs. 4%) industry workers 
were larger in the OHS recruits than in the FIOH recruits. 
In contrast, the proportion of OHS recruit participants 
working in other fields (12%) was lower than among those 
recruited by FIOH (52%). The proportion of participants 
working in the health and social care field (46% vs. 44%) 
did not differ between the recruitment procedures.
Study design
The study design was planned as a clinical randomized 
controlled trial (RCT). A total of 83 participants were ran-
domized into gCBT-I, sCBT-I, or SH education (Fig. 1). 
Randomization was conducted using adaptive stratified 
sampling (minimization) so that age, gender, and the ISI 
sum score during the assessment phase averaged the same 
in each intervention type. However, randomization was 
only partial because aviation industry participants were 
not randomized into the gCBT-I due to unsuitability of the 
group treatments in their OHS. The measurements were 
conducted before intervention (T1), after the intervention 
(T2), and at a 6-month follow-up (T3). During the T1, T2, 
and T3 phases 90%, 71%, and 59% of the included partici-
pants attended the measurements, respectively.
Included (N=83) 
Assessed for eligibility (N=112)
Randomized into group-based CBT-I intervention 
(n=30)
Randomized into self-help-based CBT-I
intervention (n=29)
Randomized into sleep hygiene education  
intervention (n=24)
T1  
Before intervention measurements (n=26) 
Unable to participate because of shifts (n=3) 
Drop-out unknown (n=1) 
Attending group-based CBT-I intervention 
(n=24)
Unable to participate because of shifts (n =1) 
Drop-out unknown during treatment (n=1)    
Attending self-help-based CBT-I intervention 
(n=19)
Drop-out unknown before treatment (n=3) 
Drop-out unknown during treatment (n=5)    
T2
After intervention measurements (n=20)  
Drop-out unknown (n=4) 
T3
Six-month follow-up measurements (n= 18) 
Drop-out unknown (n=2) 
T1
Before intervention measurements (n=27) 
No time to participate (n=1)  
Drop-out unknown (n=1) 
T1
Before intervention measurements (n=22) 
Drop-out unknown (n=2) 
T2
After intervention measurements (n=19) 
T2
After intervention measurements (n=20) 
Drop-out unknown (n=1) 
Somatic reason for insomnia (n=1) 
T3
Six-month follow-up measurements (n=16) 
Drop-out unknown (n=3) 
T3
Six-month follow-up measurements (n=15)  
Drop-out unknown (n=5) 
Excluded (n=29): 
Untreated other sleep or mental health problem (n=10) 
Refused to participate (n=8) 
Sub-clinical insomnia (n=7) 
Did not meet shift work or age criteria (n=4) 
Attending sleep hygiene education intervention 
(n=22) 
Fig. 1  Participant flowchart
539International Archives of Occupational and Environmental Health (2020) 93:535–550 
1 3
Measures
The primary outcome measure was perceived severity of 
insomnia, measured with the ISI sum score (Bastien et al. 
2001).
Insomnia symptoms and sleep were assessed using a 
sleep diary (Carney et al. 2012), which contained questions 
on SOL, WASO, time in bed (TIB), and restedness after 
sleep. Total sleep time (TST) (= TIB – SOL – WASO) and 
sleep efficiency (SE) (= TST/TIB × 100) were calculated 
afterwards. Participants additionally appraised their recovery 
after a shift (Kinnunen and Feldt 2013). They kept a sleep 
diary for 2 weeks during all the measurement phases.
We also evaluated insomnia symptoms and sleep using 
GENEActive (Activinsights Ltd. Cambs, UK) actigraphs. 
Actigraph recordings were conducted while the sleep diaries 
were being kept. The participants wore the actigraphs on 
their non-dominant wrists for 24 h a day and were instructed 
to press a button when they began trying to sleep and when 
they woke up. The epoch length used was 1 min. From the 
actigraph data, we analysed four sleep parameters (SOL, 
WASO, TST, and SE) using Sleep Analysis 7.40 (CamNtech, 
Cambridge, UK) and medium sensitivity.
In addition to the ISI, participants completed other ques-
tionnaires at each measurement phase.
Sleep-related dysfunctional cognitions were assessed 
using the 16-item version of Dysfunctional Beliefs and Atti-
tudes about Sleep (DBAS) (Morin et al. 2007). Symptoms of 
burnout were assessed using the Shirom-Melamed Burnout 
Measure (SMBM) (Shirom and Melamed 2006). Depression 
symptoms were assessed using the Beck Depression Inven-
tory (BDI) (Beck et al. 1988). Trait of worry was assessed 
Table 1  Demographic and clinical characteristics of participants of different interventions [means (M), standard deviations (SD), medians 
(Mdn), and ranges (RG)], total sample and separately
a Insomnia Severity Index [no insomnia (0 − 7 points), subthreshold insomnia (8 − 14 points), moderate (15 − 21) or severe (22 − 28 points) 
insomnia]







Age (years), Mdn (RG) 45 (21 − 60) 45 (22 − 59) 41 (21 − 60) 47 (25 − 59)
Sex, n (%)
 Women 56 (75) 18 (69) 21 (78) 17 (77)
Marital status, n (%)
 Married/cohabiting 39 (52) 12 (46) 17 (63) 7 (32)
Educational level, n (%)
 Lower secondary or primary 26 (35) 11 (42) 10 (37) 5 (23)
 Higher secondary 22 (29) 9 (35) 6 (22) 7 (32)
 Master’s degree 6 (8) 0 4 (15) 2 (9)
Professional field, n (%)
 Health or social care 34 (45) 13 (50) 10 (37) 11 (50)
 Bakery industry 13 (17) 7 (27) 4 (15) 2 (9)
 Aviation industry 9 (12) 1 (4) 5 (19) 3 (14)
 Other 19 (25) 5 (19) 8 (30) 6 (28)
Shift work schedule, n (%)
 Three-shift 40 (53) 13 (50) 16 (59) 11 (50)
 Irregular 18 (24) 5 (19) 8 (30) 5 (23)
 Two-shift excluding night shift 10 (13) 6 (23) 1 (4) 3 (14)
 Two-shift including night shift 7 (9) 2 (8) 2 (7) 3 (14)
Duration of shift work (years), M (SD) 16.3 (8.9) 14.3 (0.4) 17.3 (9.3) 17.6 (7.6)
Duration of insomnia, years, Mdn (RG) 5.0 (0.75 − 25) 6.5 (1 − 25) 5.0 (0.83 − 20) 3.0 (0.75 − 20)
ISI during assessment phase, M (SD)a 16.3 (4.3) 16.3 (4.2) 16.4 (4.6) 16.3 (4.3)
Sleep-promoting medication, n (%) 48 (64) 17 (65) 19 (70) 12 (55)
Features of shift work disorder, n (%) 37 (49) 10 (38) 12 (44) 15 (68)
Comorbid diseases, n (%)
 None 31 (41) 9 (35) 11 (41) 11 (50)
 Physical 38 (51) 14 (54) 13 (48) 11 (50)
 Mental 6 (8) 3 (12) 3 (11) 0
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using the Penn State Worry Questionnaire (PSWQ) (Meyer 
et al. 1990). Health-related quality of life was assessed using 
the Finnish version of the RAND 36-Item Health Survey, 
which measures eight facets of the quality of life (Aalto et al. 
1999; Hayset al. 1993). Two summary scores used in the pre-
vious study (Jarvinen et al. 2003) served as the final scores: 
the physical component summary (PCS) and the mental 
component summary (MCS). In addition, the participants 
evaluated treatment effectiveness after the intervention and 
at a 6-month follow-up by answering a question from the 
Consumer Reports Survey (CRS) (Seligman 1995) on the 
treatments’ global effectiveness in improving their overall 
life situations and well-being. The participants filled out the 
questionnaires using the Internet-based programmes Digium 
(until July 2017) and Questback (after July 2017), to which 
they had their own Secure Sockets Layered (SSL) link.
Interventions
The gCBT-I intervention consisted of six group sessions 
(each lasting 90 min) led by a psychologist. The first five 
sessions were held weekly and the last one 4 weeks after the 
fifth session. Each group consisted of four to six participants, 
who received a workbook containing instructions and tasks 
for each session (60 pages in total).
The sCBT-I intervention consisted of six recorded slide 
show sessions (each lasting 10 − 35 min) and four relaxation 
and mindfulness recordings (each lasting 8 − 12 min) that 
the participants watched and listened to on a tablet computer 
they received for the treatment period. Each slide show and 
additional recordings were scheduled to be activated weekly 
on the computer. Participants additionally received the same 
workbook as the gCBT-I intervention participants. Partici-
pants had one individual session with a nurse before the 
treatment, during which the nurse gave them instructions 
on how to use the self-help material. The session after the 
self-help programme was used to review each participant’s 
feedback and experiences (both lasting 30 min).
The SH education intervention consisted of one indi-
vidual session (45 min) delivered by a nurse. She told the 
participant about sleep hygiene and gave them a short work-
book containing instructions (six pages) and space for the 
participant’s personal goals to improve their sleep hygiene.
The contents of the treatments are summarized in Table 2. 
The CBT-I interventions were based on the general CBT-I 
model (Morin et al. 2015). However, we modified the behav-
ioural methods and sleep and alertness hygiene instructions, 
Table 2  Summary–contents of group and self-help-based sessions of cognitive behavioural therapy for shift workers with chronic insomnia. The 
contents of the sleep hygiene education were similar to that of session two, excluding relaxation training
Session 1: sleep information
 Normal sleep processes (e.g. sleep physiology), insomnia, sleep and wakefulness during different shifts, and treatment principles
 Individual factors affecting sleep and insomnia
 Individual goals for the treatment
 Abbreviated progressive relaxation training
Session 2: sleep and alertness hygiene
 Sleep hygiene instructions (e.g. caffeine consumption and pre-sleep routines)
 Alertness hygiene instructions (e.g. well-timed naps and other breaks)
 Making plans for improving sleep and alertness hygiene
 Cue-controlled relaxation training
Session 3: behavioural methods and hypnotic discontinuation
 Scheduling sleep, wake, and light in different shifts based on circadian principles
 Reshaping sleep patterns (stimulus control or modified sleep restriction)
 Individual plan for hypnotic discontinuation if needed
Session 4 and 5: cognitive methods
 Sleep-disturbing cognitive processes
 Developing alternative ways to handle planning, worrying, and thought racing before bedtime and at night (cognitive worry control, thought 
blocking, peaceful place imagery training, and mindfulness training)
 Cognitive restructuring of individual sleep-disturbing beliefs and attitudes to sleep and insomnia
Session 6: follow-up, refresher of CBT principles, and feedback
 Follow-up through sleep diary
 Integrating and seeking advice from previous sessions. Compiling an individual summary of helpful methods and how to maintain implemen-
tation after treatment
 Instructions for possible recurrence of insomnia symptoms
 Evaluating the helpfulness of treatment
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as in our earlier study (Jarnefelt et al. 2012). Behavioural 
sleep restriction was modified so that one extra hour in bed 
was allowed in one to three sleep periods in cases of substan-
tial shift work-related sleep debt. In addition, participants 
received information on how to schedule sleep, manage 
sleep debt, or promote sleep and alertness while working 
in shifts: e.g. well-timed naps, eating and exercise, and the 
use of eye covers and earplugs while sleeping. The contents 
of the SH education were similar to the sleep and alertness 
hygiene contents (Session two) of the CBT-I interventions.
The five gCBT-I groups had a total of 24 participants 
(Fig. 1). Eleven participants (42%) attended five to six ses-
sions (only one attended all six sessions), nine participants 
(35%) attended three to four sessions, and four participants 
(19%) attended one to three sessions. If they missed ses-
sions, the participants “caught up” via a workbook and short 
discussions in the next session. The sCBT-I sessions had 
24 participants altogether, five of which only attended the 
first introduction session and discontinued the study before 
the feedback session. The SH intervention session had 22 
participants.
Treatment providers
The gCBT-I sessions were led by four psychologists and 
the sCBT-I and SH sessions by 16 nurses from the OHS 
units. We used the following methods to ensure the integrity 
of treatment allocations: (1) Nurses and psychologists par-
ticipated in a short course on insomnia, CBT-I principles, 
and instructions for the interventions. The course comprised 
12 h, split into two training sessions led by the FIOH psy-
chologist; (2) The CBT-I and SH materials modified for a 
shift work setting were created by the FIOH psychologist 
and the sleep medicine specialist. The materials comprised 
take-home workbooks for the participants, PowerPoint pres-
entations for each session, and a guide for treatment provid-
ers containing implementation guidelines; (3) the FIOH psy-
chologist offered the OH nurses and psychologist an ongoing 
mentoring option.
Statistical methods
Power calculations conducted during the planning stage of 
the study were based on the average clinically significant 
improvement in ISI (Morin et al. 2011), the SDs in the ISI, 
and the number of dropouts in our previous CBT-I study 
(Jarnefelt et al. 2012). The calculations revealed that a total 
sample size of 90 individuals (30 per group) had 90% power 
(α = 0.05, two tail) to reject the null hypothesis of no signifi-
cant improvement in insomnia severity following the CBT-I 
treatments.
We assessed the possible differences in the demo-
graphic or clinical characteristics between participants 
randomized into different interventions using One-Way 
ANOVAs if a variable was normally distributed and using 
the Kruskal–Wallis or χ2 tests if a variable was not normally 
distributed. Likewise, we assessed the possible differences 
between the demographic and clinical characteristics of the 
participants recruited by the OHS centers and FIOH, and in 
addition, the differences in the outcomes over the measure-
ment phases between the SWD and non-SWD participants 
using independent t tests, Mann–Whitney U tests, or χ2 tests.
We analysed the results of the participants who had par-
ticipated in both the T1 and T2 measurements. We used an 
intention-to-treat analysis at T3, in which each missing value 
was replaced by the value from the T2 phase, respectively, 
using the methodology of an earlier trial of insomnia (Jacobs 
et al. 2004).
For further analyses, the participants were divided into 
three response groups based on the magnitude of ISI reduc-
tion at T3: (1) The Responders’ ISI had decreased by at least 
seven points, representing at least a one-category reduction 
in ISI (Bastien et al. 2001); (2) the Partial responders’ ISI 
had decreased by three to six points, representing only a 
minor change in insomnia symptoms; and (3) the Non-
responders’ ISI had not decreased by more than two points, 
had not changed at all, or had increased all indicating no 
improvement in symptoms.
We analysed the main effects and the interactions in each 
outcome variable over the measurement phases and with 
contrasts (T1-T2 and T1-T3) to compare both CBT-I inter-
ventions to the SH control intervention and to compare SWD 
and non-SWD participants using a general linear model 
(ANOVA with repeated measurements) if the variable was 
normally distributed. We used a generalized linear model 
(using Wald χ2) with an exchangeable working correlation 
matrix if the variable was not normally distributed. The χ2 
-test was used to compare both CBT-I interventions to the 
SH intervention and to compare SWD and non-SWD par-
ticipants in the deviations of the three treatment response 
groups. A p value of < 0.05 was considered statistically sig-
nificant. We calculated the effect sizes (Cohen’s d) of the 
statistically significant results to estimate impact.
We used IBM SPSS Statistics version 25 for the analyses.
Results
Questionnaire results
Neither the gCBT-I nor the sCBT-I intervention differed 
from the SH control intervention in terms of the reduction of 
the main outcome of the study, i.e. the perceived severity of 
insomnia (ISI). Regardless of the intervention, ISI decreased 
(23% from T1 average) significantly over the measurement 
phases (F2,112 = 21.04, p < 0.001). Compared to the T1 phase, 
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ISI decreased during the T2 phase (F1,56 = 33.85, p < 0.001, 
d = 0.68) and at T3 (F1,56 = 25.58, p < 0.001, d = 0.63).
Based on the above-mentioned ISI response grouping, 
the interventions differed in the reduction magnitude of ISI 
( 2
4
 = 8.62, p = 0.07), showing a trend that more respondents 
were in the gCBI-I (40%) than in the SH control intervention 
(5%). The number of respondents in the sCBT (16%) and SH 
intervention did not differ significantly. Respectively, there 
were more partial respondents in the SH (45%) than in the 
gCBT-I intervention (20%). The number of partial respond-
ents did not differ significantly between the sCBT (32%) and 
SH control intervention. The number of non-respondents 
did not differ significantly (gCBT-I 40%, sCBT-I 53%, and 
SH 50%).
We found no significant differences in the reduction of 
sleep-related dysfunctional beliefs measured by DBAS 
between the CBT-I and SH control intervention participants. 
Regardless of the intervention, beliefs decreased signifi-
cantly (11%) over the measurement phases (F2,112 = 12.77, 
p < 0.001). Compared to the T1 phase, DBAS decreased dur-
ing the T2 phase (F1,56 = 15.32, p < 0.001, d = 0.38) and at 
T3 (F1,56 = 27.70, p < 0.001, d = 0.38).
Neither the gCBT-I nor the sCBT-I intervention differed 
from the SH control intervention in terms of the reduc-
tion of burnout and stress symptoms measured by SMBM. 
Regardless of the intervention, SMBM decreased signifi-
cantly (11%) over the measurement phases (F2,112 = 9.28, 
p < 0.001). Compared to the T1 phase, SMBM decreased 
during the T2 phase (F1,56 = 13.69, p < 0.001, d = 0.40) and 
at T3 (F1,56 = 13.25, p = 0.001, d = 0.40).
The interaction effect of depression symptoms measured 
by BDI between the interventions was non-significant, but 
we observed a trend in which symptoms decreased sig-
nificantly more at T3 among the gCBT-I intervention par-
ticipants than among those in the SH control intervention 
( 2
1
 = 4.04, p = 0.044, d = 0.54). Regardless of the interven-
tion, depression symptoms decreased (43%) significantly 
during the measurement phases ( 2
2
 = 8.75, p = 0.013). Com-
pared to the T1 phase, BDI had decreased at T3 ( 2
1
 = 8.48, 
p = 0.004, d = 0.82).
An interaction effect occurred in the trait of worry meas-
ured by PSWQ ( 2
2
 = 7.01, p = 0.030), showing a greater 
decrease at T3 among the gCBT-I intervention partici-
pants than among the SH control intervention participants 
( 2
1
 = 3.83, p = 0.050, d = 0.53). Regardless of the interven-
tion, trait of worry decreased significantly (10%) over the 
measurement phases ( 2
2
 = 16.67, p < 0.001). Compared to 
the prior intervention phase, PSWQ had decreased at T3 
( 2
1
 = 15.69, p < 0.001, d = 1.20).
The physical component of the health-related quality of 
life measured by RAND showed no significant differences 
between the interventions or showed significant changes 
regardless of the intervention. We also found no significant 
differences in the improvement of the mental component 
of the quality of life among both the CBT-I and SH control 
intervention participants. Regardless of the interventions, we 
observed a trend in which the mental quality of life improved 
(9%) over the measurement phases ( 2
2
 = 5.84, p = 0.054). 
Compared to the T1 phase, the mental quality of life had 
improved at T3 ( 2
1
 = 5.23, p = 0.022, d = 0.62).
The participants’ evaluations of the global effectiveness 
of the interventions in improving their overall life situa-
tions and well-being differed ( 2
2
 = 9.32, p = 0.009). Paired 
comparisons showed that the sCBT-I intervention partici-
pants ( 2
1
 = 4.40, p = 0.036, d = 0.57) and indicatively also 
the gCBT-I intervention participants ( 2
1
 = 3.35, p = 0.067, 
d = 0.49) evaluated greater improvement than the SH control 
intervention participants. The evaluations did not change 
significantly at T3.
The summary data of all the questionnaire results are rep-
resented in Table 3.
Sleep diary
SOL, WASO, SE, and the usage of SPMs did not dif-
fer between the interventions or show significant changes 
regardless of the intervention. The ranges of SOL, WASO, 
and SE were quite large, but these outcomes were not gener-
ally significantly impaired even during the T1 phase (Mdns 
of SOL 23 min, WASO 20 min, and SE 90%). Likewise, the 
usage of SPMs varied from 0 to 100% for all nights (Mdn 
7.1%).
TST showed an interaction effect between interventions 
(F4 = 2.57, p = 0.043). TST showed an increasing trend 
(12 min) during the T2 phase among the participants of both 
CBT-I-interventions but decreased, respectively, among the 
SH education participants (F2 = 2.46, p = 0.095).
We found no significant response differences either in 
self-reported restedness after a sleep period or in recovery 
after a shift between the CBT-I and SH control interven-
tion participants. Both outcomes improved significantly 
(both 7%) regardless of the intervention (F2,100 = 4.35, 
p = 0.006; F2,102 = 5.35, p = 0.006). Compared to the T1 
phase, restedness and recovery experience had increased at 
T3 (F1,51 = 6.63, p = 0.013, d = 0.40; F1,50 = 7.41, p = 0.009, 
d = 0.27, respectively).
Table 4 represents the summary data of the sleep diary 
results at all measurement phases.
Actigraphy
SOL, WASO, and SE did not differ between the interven-
tions or show significant changes regardless of interven-
tion. Similar to the sleep diary results, the ranges of the 
actigraphy outcomes were quite large, but SOL and SE were 
not generally significantly impaired during the T1 phase 
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(Mdns of SOL 7 min and SE 86%). However, actigraphy-
based WASO was long during the T1 phase (Mdn of WASO 
48 min).
We also found no significant differences in the improve-
ment of TST when we compared the CBT-I to the SH 
control intervention participants. Regardless of the 
intervention type, TST improved significantly  (F2,98 = 3.42, 
p = 0.037). Compared to T2, TST had increased (12 min) 
at T3  (F1,49 = 5.42, p = 0.024, d = 0.24).
The summary data of the actigraphy results in all meas-
urements phases are presented in Table 5.
Table 3  Means (M) and standard deviations (SD) or medians (Mdn) 
and ranges (RG) of questionnaire outcomes at the before intervention 
(T1), after intervention (T2), and six-month follow-up (T3) phases in 
the total sample and separately among the participants of the different 
interventions
a Insomnia Severity Index (scale 0 − 28)
b Dysfunctional beliefs and attitudes about sleep (0 − 10)
c Shirom-Melamed burnout measure (1 − 7)
d Beck depression inventory (0 − 63)
e Penn State Worry Questionnaire (16 − 80)
f RAND SF-36 (0 − 100): physical component summary (PCS), mental component summary (MCS)
g Consumer Reports Survey question concerning the global effectiveness of treatments to improve overall life situations and well-being [1(not at 
all)–7(decisive impact)]






 T1 14.0 (5.0) 15.4 (5.0) 13.6 (5.2) 13.0 (4.8)
 T2 10.7. (4.7) 10.9 (5.4) 10.7 (4.4) 10.6 (4.7)
 T3 10.8 (5.1) 11.1 (5.7) 10.7 (4.9) 10.6 (5.0)
DBAS, M (SD)b
 T1 5.4 (1.6) 5.5 (1.5) 6.0 (1.3) 4.8 (1.7)
 T2 4.8 (1.6) 4.8 (1.4) 5.0 (1.8) 4.6 (1.7)
 T3 4.8 (1.6) 4.7 (1.8) 5.2 (1.4) 4.4 (1.7)
SMBM, M (SD)c
 T1 3.7 (1.0) 3.9 (1.2) 3.8 (0.7) 3.5 (0.9)
 T2 3.3 (1.0) 3.3 (1.1) 3.1 (0.9) 3.3 (0.9)
 T3 3.3 (1.0) 3.4 (1.1) 3.5 (0.7) 3.2 (1.0)
BDId, Mdn (RG)d
 T1 7 (0 − 24) 9 (0 − 24) 7 (1 − 15) 6.5 (0 − 18)
 T2 5 (0 − 21) 7 (0 − 20) 4 (0 − 17) 5 (0 − 21)
 T3 4 (0 − 23) 4 (0 − 14) 3 (0 − 17) 5 (0 − 23)
PSWQ, Mdn (RG)e
 T1 40 (23 − 66) 47.5 (23 − 66) 40 (24 − 60) 38.5 (26 − 63)
 T2 35 (18 − 66) 42.5 (18 − 66) 34 (21 − 64) 32 (23 − 64)
 T3 36 (16 − 65) 37 (16 − 63) 38 (24 − 60) 31 (22 − 65)
RAND-PCS, Mdn (RG)f
 T1 81.3 (40.0 − 100) 75.6 (47.5 − 100) 83.8 (50.6 − 100) 81.6 (40.0 − 97.5)
 T2 85.6 (33.6 − 100) 79.7 (38.8 − 100) 86.3 (45.0 − 97.5) 82.2 (33.8 − 97.5)
 T3 85.0 (30.6 −98.8) 89.1 (30.6 − 98.8) 81.9 (50.0 − 96.3) 85.3 (40.6 − 97.5)
RAND-MCS, Mdn (RG)f
 T1 73.9 (19.6 − 94.3) 70.8 (19.6 − 94.3) 79.6 (42.3 − 92.8) 74.9 (40.8 − 91.0)
 T2 76.0 (37.7 − 96.5) 73.8 (37.7 − 93.3) 83.1 (59.9 − 96.5) 77.8 (49.3 − 88.0)
 T3 80.8 (37.7 − 100) 75.4 (37.7 − 100) 84.8 (52.7 − 92.8) 81.1 (44.2 − 96.5)
CRS, Mdn (RG)g
 T2 4 (1 − 6) 5 (1 − 6) 5 (1 − 6) 2 (1 − 5)
 T3 3.5 (1 − 6) 4 (1 − 6) 4 (1 − 6) 2 (1 − 4)
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Further analysis of SWD features
When analysing the demographic and clinical characteris-
tics of the participants with and without SWD features, we 
found that non-SWD participants had significantly more 
diagnosed comorbid diseases, especially more comorbid 
mental disorders ( 2
3
 = 10.58, p = 0.005). All six partici-
pants with mental disorders had no SWD, whereas 68% of 
participants without any comorbid diseases had SWD. In 
addition, non-SWD participants more commonly used SPM 
every night or almost every night ( 2
4
 = 10.41, p = 0.034). 
Fourteen participants used SPM every night or almost every 
night and 12 of these had no SWD. Non-SWD participants 
also had a higher ISI during the assessment phase than SWD 
participants [t72 = 2.40, p = 0.019; ISI: M 17.5 (SD 4.5) vs. 
M 15.2 (SD 3.9)]. SWD groups did not differ in terms of 
other demographic or clinical characteristics.
We observed no interaction effect between the SWD 
groups in terms of the average ISI sum score over the meas-
urement phases or in the ISI-based treatment response 
group. In other words, both SWD groups improved similarly. 
However, the average ISI over all the measurement phases 
was higher among non-SWD participants than among SWD 
Table 4  Medians (Mdn) and 
ranges (RG) or means (M) 
and standard deviations (SD) 
of sleep diary outcomes at the 
before intervention (T1), after 
intervention (T2), and 6-month 
follow-up (T3) phases in the 
total sample and separately 
among the participants of the 
different interventions
a Sleep-onset latency
b Wake after sleep onset
c Total sleep time
d Sleep effiency
e Sleep-promoting medication (% of nights)
f Restedness after sleep period 1(good)−5(poor)
g Recovery after a shift 1 (well)–5(poorly)
Sleep Diary Total sample (n = 54) Group-based CBT-I (n = 20) Self-help-based 




SOL (min), Mdn (RG)a
 T1 22.7 (4.3 − 74.6) 20.0 (4.3 − 74.6) 20.0 (7.9 − 57.5) 28.9 (6.9 − 60.7)
 T2 21.9 (3.6 − 73.9) 22.0 (5.0 − 64.6) 23.4 (3.6 − 73.9) 19.4 (6.6 − 73.2)
 T3 20.3 (3.9 − 93.6) 18.4 (3.9 − 64.6) 22.0 (6.8 − 76.4) 20.7 (4.9 − 93.6)
WASO (min), Mdn (RG)b
 T1 19.6 (0 − 147.1) 20.4 (0.1 − 147.1) 15.0 (1.6 − 55.4) 23.6 (0 − 98.1)
 T2 22.9 (0 − 103.8) 24.8 (0 − 84.8) 22.3 (0 − 63.9) 23.6 (0 − 103.8)
 T3 21.4 (0 − 126.1) 35.4 (0 − 126.1) 22.5 (1.1 − 49.3) 14.7 (0 − 99.5)
TST (h), M (SD)c
 T1 7.0 (0.9) 6.7 (0.8) 7.2 (0.8) 7.2 (1.1)
 T2 7.1 (1.0) 6.9 (0.7) 7.4 (1.0) 7.0 (1.3)
 T3 7.2 (1.0) 7.1 (0.8) 7.1 (0.9) 7.4 (1.2)
SE (%), Mdn (RG)d
 T1 89.8 (66.6 − 97.8) 90.5 (66.6 − 96.0) 90.0 (78.5 − 96.9) 87.5 (76.2 − 97.8)
 T2 89.4 (69.6 − 98.5) 90.3 (73.8 − 96.6) 91.7 (79.8 − 98.5) 88.6 (69.6 − 98.5)
 T3 89.5 (73.1 − 98.3) 88.7 (73.1 − 96.0) 89.2 (76.7 − 96.0) 91.3 (79.0 − 98.3)
SPM, Mdn (RG)e
 T1 7.1 (0 − 100) 15.7 (0 − 100) 21.4 (0 − 100) 0 (0 − 100)
 T2 7.1 (0 − 100) 0 (0 − 100) 7.1 (0 − 100) 0 (0 − 100)
 T3 0 (0 − 100) 0 (0 − 100) 7.1 (0 − 100) 0 (0 − 100)
Restedness, M (SD)f
 T1 2.8 (0.5) 2.9 (0.4) 2.7 (0.5) 2.9 (0.6)
 T2 2.7 (0.5) 2.7 (0.5) 2.6 (0.5) 2.8 (0.6)
 T3 2.6 (0.5) 2.7 (0.5) 2.6 (0.5) 2.6 (0.4)
Recovery, M (SD)g
 T1 2.7 (0.7) 2.7 (0.6) 2.6 (0.6) 2.7 (0.8)
 T2 2.7 (0.7) 2.8 (0.6) 2.6 (0.8) 2.8 (0.6)
 T3 2.5 (0.8) 2.6 (0.8) 2.3 (0.9) 2.6 (0.7)
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participants [F1 = 5.55, p = 0.022; ISI: M 13.04 (SD 5.7) vs. 
M 10.5 (SD 4.2)].
An interaction effect of the average DBAS was also 
non-significant, but a trend emerged showing that at T3 
(F1 = 6.14, p = 0.016) DBAS had decreased significantly 
more among non-SWD participants (reduction of M 1.0, 
SD 1.1 points) than among SWD participants (reduction of 
M 0.3, SD 0.8 points). In addition, the average DBAS over 
all the measurement phases was higher among the non-SWD 
than among the SWD participants [F1 = 6.23, p = 0.016; 
DBAS: M 5.4 (SD 1.7) vs. M 4.5 (SD 1.4)].
We found no interaction effect between the SWD groups 
in terms of BDI. However, the BDI over all the measurement 
phases was higher among the non-SWD than among the 
SWD participants [ 2
1
 = 4.00, p = 0.046; Mdn 7 (RG 0 − 24) 
vs. Mdn 4 (RG 0 − 23)].
We observed an interaction effect between measurement 
phases and SWD groups ( 2
2
 = 6.25, p = 0.012), showing that 
at T3, non-SWD participants evaluated the global effective-
ness of the intervention better in improving their overall life 
situations and well-being than SWD participants [ 2
1
 = 6.25, 
p = 0.012, d = 0.90; Mdn 4 (RG 1 − 6) vs. Mdn 3 (RG 1 − 6)]. 
We saw no differences between SWD and non-SWD partici-
pants in their evaluations of treatment effectiveness over all 
the measurement phases.
The use of SPM decreased among non-SWD partici-
pants (from 44.2 to 30.3% of nights at T2 and to 34.0% of 
nights at T3) and increased among SWD participants (from 
9.7 to 15.0% of nights at T2 and to 10.5% of nights at T3) 
( 2
1
 = 6.15, p = 0.013, d = 0.89). The use of SPM was higher 
among SWD than among non-SWD participants over all the 
measurement phases [ 2
1
 = 8.51, p = 0.004; Mdn 14.3% of 
nights (RG 0-100) vs. Mdn 0% of nights (RG 0 − 100)].
The interaction effect of the actigraphic TST was non-
significant, but a trend emerged at T3 showing increased 
actigraphic TST among non-SWD participants (from 6.7 to 
7.0 h) and decreased actigraphic TST among SWD partici-
pants (from 6.8 to 6.7 h) (F1 = 8.06, p = 0.007). The average 
actigraphic TST of the SWD and non-SWD participants did 
not differ over all the measurement phases.
The SWD groups showed no significant differences in 
term of the other outcomes.
Discussion
This partially randomized study evaluated the effective-
ness of CBT-I interventions among employees whose sleep 
and wake processes were affected by irregular and sleep-
disturbing shifts. Our results showed no significant differ-
ences between shift workers’ sleep improvements in the g- 
and sCBT-I interventions and the SH control intervention. 
Indicated by a decrease in the perceived severity of insom-
nia (ISI), insomnia improved moderately among the shift 
Table 5  Medians (Mdn) and 
ranges (RG) or means (M) 
and standard deviations (SD) 
of actigraphy outcomes at the 
before intervention (T1), after 
intervention (T2), and six-
month follow-up (T3) phases in 
the total sample and separately 
among participants of different 
interventions
a Sleep-onset latency
b Wake after sleep onset




Total sample (n = 52) Group-based CBT-I (n = 19) Self-help-based 




SOL (min), Mdn (RG)a
 T1 6.9 (0.7 − 23.1) 5.7 (1.4 − 19.9) 6.4 (0.7 − 20.0) 9.9 (1.7 − 23.1)
 T2 8.2 (0.4 − 40.2) 6.1 (1.6 − 26.8) 9.3 (2.4 − 40.2) 9.5 (0.4 − 36.4)
 T3 8.0 (0.9 − 36.4) 4.0 (0.9 − 29.7) 8.3 (2.4 − 27.4) 8.2 (1.4 − 36.4)
WASO (min), Mdn (RG)b
 T1 48.1 (28.7 − 81.7) 43.2 (28.7 − 75.5) 50.4 (30.9 − 81.7) 48.0 (32.1 − 70.0)
 T2 45.8 (23.9 − 82.0) 37.1 (26.8 − 82.0) 56.2 (26.6 − 82.0) 44.8 (23.9 − 59.4)
 T3 48.2 (23.9 − 86.0) 43.8 (28.0 − 82.7) 53.5 (29.2 − 86.0) 47.4 (23.9 − 70.4)
TST (h), M (SD)c
 T1 6.8 (0.7) 6.7 (0.6) 6.7 (0.7) 7.0 (0.8)
 T2 6.7 (0.9) 6.6 (0.7) 6.8 (1.0) 6.6 (1.0)
 T3 6.9 (0.8) 6.9 (0.7) 6.8 (0.8) 7.0 (1.0)
SE (%), Mdn (RG)d
 T1 86.1 (72.2 − 92.6) 88.0 (79.3 − 92.6) 85.5 (72.2 − 90.1) 86.5 (81.2 − 90.5)
 T2 86.3 (69.3 − 92.6) 88.1 (75.8 − 92.5) 84.0 (69.3 − 92.0) 87.7 (78.1 − 92.6)
 T3 86.0 (72.1 − 92.2) 88.1 (78.4 − 92.2) 85.2 (72.1 − 90.1) 86.0 (78.1 − 91.3)
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workers after all the interventions. The alleviation of mood 
symptoms seemed to be the main benefit of gCBT-I inter-
vention compared to the SH control intervention. Half of the 
participants were evaluated as having features of SWD. In 
this study, non-SWD participants had a more severe clinical 
overall picture and benefitted more from the interventions 
than SWD participants.
The first aim of our study was to evaluate the effective-
ness of the g- and sCBT-I interventions among shift workers 
compared to short SH education. We found no significant 
differences between the CBT-I interventions and the SH con-
trol intervention, nor in the main outcomes of ISI, DBAS, 
burnout and stress symptoms, or quality of life. These results 
are in line with a study by Schiller et al. (2018), which 
showed a significant effect on insomnia symptoms after 
CBT-I compared to a waiting list control only after shift 
workers were excluded from the data. However, our previ-
ous non-randomized study showed no difference between 
the improvements among day and shift media workers 
after CBT-I (Jarnefelt et al. 2014). In addition, a non-ran-
domized study by Peter et al. (2019) showed improvement 
in ISI among shift workers after online CBT-I. Regardless 
of the intervention, ISI improved moderately in our current 
study, and sleep-related dysfunctional beliefs along with 
burnout and stress symptoms showed small improvements 
lasting up to the 6-month follow-up after all three interven-
tions. A trend also emerged in which the mental compo-
nent of health-related quality of life improved moderately 
at 6-month follow-up. These overall results are parallel to 
those observed in Peter et al. (2019) but weaker than results 
obtained in earlier face-to-face and self-help CBT-I stud-
ies (Cheng and Dizon 2012; Morin et al. 2015; Okajima 
et al. 2011) or results seen in our above-mentioned gCBT-I 
study among shift workers, which showed medium to large 
effects on ISI, DBAS, and the quality of life after the inter-
vention (Jarnefelt et al. 2012). Based on ISI, 70 − 80% of 
participants are generally estimated to achieve a response 
after CBT-I (Morin et al. 1999), while, depending on the 
intervention, only 5 − 40% of the participants in our cur-
rent study achieved a response, showing a trend of a better 
response after gCBT-I than after SH education. This prob-
ably reflects that certain shift workers with insomnia benefit 
more from gCBT than solely from SH education.
The main difference between the studied interventions 
appeared in the outcomes related to mental health. The 
gCBT-I of our study was effective in improving the mental 
health of shift workers, as also observed in earlier stud-
ies (Jarnefelt et al. 2012; Okajima et al. 2011; Peter et al. 
2019). The trait of worry had decreased substantially at 
6-month follow-up, the interaction effect showing a larger 
reduction after the gCBT-I than SH control intervention. 
Likewise, depression symptoms decreased at 6-month fol-
low-up and we noted a trend emerging where a significant 
reduction appeared after gCBT-I. Participants of both 
CBT-I interventions additionally preferred their interven-
tions’ global effectiveness in improving their overall life 
situations and well-being compared to the SH education 
intervention participants. Many explanations potentially 
exist for the positive mental health effects after CBT-I. On 
the one hand, as CBT-I partly includes the same compo-
nents as CBT interventions for mood disorders, it probably 
directly affects the mood symptoms of insomniacs. On the 
other hand, better sleep may have indirect positive effects 
on mental health.
The sleep diary and actigraphy measurements of this 
study showed no significant changes in SOL, WASO, or SE, 
which typically improve moderately or substantially after 
CBT-I (Morin et al. 2015; Okajima et al. 2011). SOL and 
SE also showed small improvements in our previous study 
on shift workers (Jarnefelt et al. 2012), and SE improved 
after both online and face-to-face CBT-I in another study 
among shift workers (Peter et al. 2019). However, these 
sleep outcomes were not generally significantly impaired 
in our current study even before the interventions, except 
actigraphy-based WASO. The sleep diary-based TST 
showed a small increase after both CBT-I interventions but 
a decrease after SH education and actigraphy-based TST 
showed a small improvement at 6-month follow-up regard-
less of intervention. Other CBT-I studies have also shown 
this lagging effect in TST (Okajima et al. 2011). The rea-
son behind this remains unclear but suggests that CBT-I is 
superior to pharmacotherapy, as effectiveness was sustained 
and even gradually increased after discontinuation of the 
treatment. In addition, self-appraised restedness after a sleep 
period and recovery after a shift showed small improvements 
at 6-month follow-up in all intervention types. Similarly, 
restedness improved moderately in the previous study of 
gCBT-I among shift workers (Jarnefelt et al. 2012). The 
better restedness and recovery results of our current study 
may at least partly be due to increased TST along with the 
better alertness hygiene and relaxation methods used by the 
participants after the interventions.
The second aim of our study was to evaluate whether 
SWD features associated with participants’ demographic or 
clinical characteristics, the study outcomes, and the inter-
ventions’ effectiveness. Based on SS-Q (Vanttola et al. 2018) 
and the sleep diaries, in resemblance to the clinical criteria 
of SWD (American Academy of Sleep Medicine 2014), half 
of the participants were evaluated as having SWD features. 
Compared to them, the clinical picture of non-SWD partici-
pants was more severe. Firstly, non-SWD participants had 
more comorbid diseases, only they had comorbid diagnosed 
mental disorders, and they used SPMs more frequently over 
all the measurement phases. Secondly, at the assessment and 
before the intervention phases, the non-SWD participants 
perceived their insomnia as more severe, and during the 
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before intervention phase they had more severe sleep-related 
dysfunctional beliefs and depression symptoms.
We also observed differences in treatment effectiveness 
depending on the SWD type. Compared to the before inter-
vention phase, SPM usage decreased among the non-SWD 
participants and increased slightly among those with SWD 
during both the intervention phase and at 6-month follow-up. 
We noted two emerging trends at 6-month follow-up: dys-
functional beliefs decreased more among non-SWD partici-
pants and actigraphy-based TST increased among non-SWD 
and decreased among SWD participants. In addition, during 
the follow-up phase, the non-SWD participants evaluated the 
global effectiveness of their intervention better. Our results 
indicate that the main target of non-pharmacological insom-
nia interventions should be shift workers with insomnia who 
do not have SWD because their symptoms are more severe. 
As hypothesized, they also benefited from interventions 
more than those with SWD, whose insomnia is primarily 
attributed to circadian disruptions and misalignments due 
to shift work.
To summarize, based on our study CBT-I should only 
be considered if a shift worker with insomnia has clinically 
significant symptoms regardless of their shifts, or if they 
have comorbid mental disorders or symptoms. Likewise, 
certain studies show that CBT-I is effective among insomnia 
patients with comorbid mental disorders and occasionally 
also improves the comorbid disorder (Taylor and Pruiksma, 
2014). In addition, current evidence suggests that preventing 
mental health problems by CBT-I may be possible (Freeman 
et al. 2017), which supports using CBT-I also with patients 
without present mental disorders. In our study, based on 
the preference of the shift workers themselves, both CBT-I 
interventions showed superiority over short SH education. 
However, our results also reveal overall uncertainty regard-
ing the usefulness of g- and sCBT-I interventions among 
shift workers. This may be because of the sleep-disturbing 
characteristics of the participants’ work schedules (Flo et al. 
2014; Waage et al. 2014), which make improving their sleep 
through interventions impossible, as only individual factors 
are targeted. Sleep–wake disturbances can also be decreased 
through ergonomic shift scheduling by e.g. minimizing the 
proportion of night shifts (Harma et al. 2018; Sallinen and 
Kecklund 2010). In addition, OHSs should take individual 
tolerance to shift work into account (Saksvik et al. 2011). 
None of our participants had an SWD diagnosis, although 
half were evaluated as having SWD features. One possible 
reason for this is that OHS professionals have insufficient 
knowledge and experience on the evaluation of SWD. Over-
all, shift workers with insomnia probably have many etiolog-
ical factors behind their symptoms. Thus, the transdiagnostic 
sleep treatment approach (Harvey and Buysse 2018) may 
be the best solution. This approach integrates the elements 
of CBT-I, interpersonal and social rhythm therapy, and 
other evidence-based therapies to find an individually fit-
ting and effective treatment for complex and comorbid sleep 
and circadian rhythm problems. Our study also used such 
a modified CBT-I approach. In practice, the interventions 
of our study could be used and tailored based on the indi-
vidual needs of each shift worker. For example, SWD-type 
insomnia may improve enough after short SH and circadian 
adaption education and individual rescheduling of shifts if 
needed, whereas those with insomnia independent of work-
ing hours probably need more intensive CBT-I. In addition, 
these two perspectives should be combined if SWD and an 
insomnia disorder coexist.
Certain factors limit the generalizability of our results. 
The small number of differences between the interventions 
limits or contests any conclusions. In addition, we had no 
“no treatment” control group for assessing the overall effects 
of all the interventions. The comparable results between 
interventions may be explained by e.g. the intervention effect 
of the measurements, the effect caused by receiving atten-
tion to the sleeping problem, or through natural variation 
in insomnia-related symptoms. More effective treatment for 
this special group of insomniacs may have required more 
experience and expertise from the treatment providers. Our 
sample size may not have been sufficient to detect differ-
ences between the interventions. The recruited sample was 
slightly smaller than planned based on the power calcula-
tions made during the planning stage of the study. In addi-
tion, more participants discontinued than in our previous 
study (Jarnefelt et al. 2012), which decreased the final sam-
ple size and probably reduced the power of our results. One 
reason for discontinuation may have been the participants’ 
perceived poor suitability of these interventions for improv-
ing their sleeping problems. Another possible explanation 
for the weaker result is that attendance in the group meetings 
was considerably weaker in this study than in our previ-
ous study (1/24 vs. 12/23 of the participants attending all 
sessions) (Jarnefelt et al. 2012), in which the participants 
could attend during working hours. Employers should be 
encouraged to allow their employees to attend treatments 
such as this during working hours, if necessary. Otherwise, 
we did not gather systematic information concerning inter-
vention compliance among participants. Neither were the 
participants blinded for the intervention type. This may 
have negatively affected response expectations and apprais-
als, especially among the SH education participants because 
they had only one intervention session. The small sample 
size also made it impossible to compare which intervention 
works best for insomniacs with or without SWD features. In 
addition, based on the sleep diaries and actigraphy, our par-
ticipants’ sleep was not severely impaired and this may have 
affected the degree to which their sleep could have improved 
(ceiling effect), as also shown in our earlier CBT-I study 
among both day and shift workers (Jarnefelt et al. 2014). We 
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recommend paying more attention to this probable ceiling 
effect when recruiting participants for future sleep interven-
tion studies through OHS.
The generalizability of our findings also faces certain 
other limitations. Airline participants were not randomized 
into gCBT-I in the current study. Although it was quite a 
small group, mainly containing cabin attendants (12% of 
the sample), it may have affected the sCBT-I and SH edu-
cation results because of the typically very irregular and 
long working hours of this group, which possibly impair 
their sleep more than the working times in other profes-
sional fields. This shows at least a practical limitation to 
implementing gCBT-I in certain occupations. In addition, 
participants recruited by OHS and FIOH were slightly dif-
ferent in terms of shift work duration and professional field. 
The partly different recruitment processes and expertise in 
assessment and intervention methods in OHS and FIOH may 
have affected the sample and results. Participants recruited 
by FIOH were possibly more suitable for the study because 
they were preincluded through a short electronic question-
naire. In addition, FIOH had more previous expertise in 
sleep medicine and intervention methods and this may have 
positively affected the results. However, the participants 
were distributed unequally in the interventions in terms of 
this recruitment factor, which made the analysis of these 
effects unreliable. The shift work inclusion criteria for our 
study was also quite loose (only a 10% minimum of shifts 
had to be other than day shifts), making the generalizability 
of the results more uncertain because shift workers’ work-
ing times and the circadian disruption and misalignment 
related to these vary greatly. Although most of our partici-
pants clearly exceeded the minimum criteria, future studies 
should consider stricter, multi-dimensional criteria (Harma 
et al. 2015; Vanttola et al. 2019). We should also note that 
the overall sample was quite small and three out of four par-
ticipants were women. However, insomnia is generally more 
common in women (Morin et al. 2015), and they are typi-
cally over-represented (approximately 60% of participants) 
in clinical non-pharmacological insomnia trials (Morin et al. 
1999). In our current study, over half of our participants 
worked in professional fields consisting predominantly of 
female employees (e.g. nurses and cabin attendants). Future 
studies should test insomnia treatments in shift work fields 
consisting of more male employees.
This clinical RCT trial was implemented in different 
OHS contexts, showing that OHS could be a good route for 
delivering such treatments. We took SWD into account in 
our analyses as a potentially important background factor 
for insomnia among this group of people, and this is the 
strength of our study. There are still only a few studies on 
CBT-I or other non-pharmacological treatments of insom-
nia among shift workers, which makes it difficult to frame 
practical treatment guidelines in this case. Future insomnia 
treatment studies should include potential SWD already dur-
ing the screening and randomization of the participants to 
determine the best practices for shift workers with insomnia.
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